Home › Funds › Elmind Capital, LP › TYRA
Elmind Capital, LP position in TYRA
TYRA BIOSCIENCES INC COM · Health Care
Elmind Capital, LP reported holding 20,000 shares of TYRA (TYRA BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$639K, representing 0.16% of its reported portfolio and ranking #34 among its reported holdings. Elmind Capital, LP has disclosed TYRA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Elmind Capital, LP's TYRA position evolved
Elmind Capital, LP first disclosed a stake in TYRA in Q4 2025 at 350,000 shares (US$9.2M). The position peaked in Q1 2026 at 350,000 shares, worth US$13.4M. Across 3 filings, Elmind Capital, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 20,000 shares valued at US$639K — a reduction of -330,000 shares quarter over quarter.. Notable position changes include a 94% trim in Q2 2026 (shares fell 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 350.00K | $9.20M | New |
| Q1 2026 | 350.00K | $13.40M | Hold |
| Q2 2026 | 20.00K | $638.80K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TYRA and 13F data
TYRA (TYRA BIOSCIENCES INC COM) is a Health Care company. 58 other funds we track also report a position in TYRA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$389.6M), Alta Partners Management Company, L.P. (US$122.1M), Nextech Invest Ltd. (US$113.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TYRA
- RA CAPITAL MANAGEMENT, L.P. 12.20M sh · $389.62M · Q2 2026
- Alta Partners Management Company, L.P. 3.82M sh · $122.12M · Q2 2026
- Nextech Invest Ltd. 3.55M sh · $113.50M · Q2 2026
- TCG Crossover Management, LLC 3.25M sh · $103.77M · Q2 2026
- Commodore Capital LP 1.88M sh · $59.89M · Q2 2026
- Paradigm Biocapital Advisors LP 1.83M sh · $58.41M · Q2 2026
- BVF INC/IL 1.48M sh · $47.15M · Q2 2026
- 5AM Venture Management, LLC 1.03M sh · $32.88M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.02M sh · $32.48M · Q2 2026
- Caligan Partners LP 806.99K sh · $25.78M · Q2 2026
- Canaan Partners XI LLC 750.00K sh · $23.95M · Q2 2026
- Sio Capital Management, LLC 695.32K sh · $22.21M · Q2 2026
More on Elmind Capital, LP
FAQ
How long has Elmind Capital, LP held TYRA?
Elmind Capital, LP has disclosed TYRA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Elmind Capital, LP's current position in TYRA?
As of Q2 2026, Elmind Capital, LP holds 20.00K shares of TYRA (TYRA BIOSCIENCES INC COM), valued at $638.80K, representing 0.16% of its reported portfolio and ranking #34.
Has Elmind Capital, LP been buying or selling TYRA?
In the latest 13F filing (Q2 2026), Elmind Capital, LP reduced its position in TYRA. The position peaked in Q1 2026 at 350.00K shares.
Which other funds hold TYRA?
Other major institutional holders of TYRA include RA CAPITAL MANAGEMENT, L.P., Alta Partners Management Company, L.P., Nextech Invest Ltd., among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.